Study of A New Contact Lens Cleaning and Disinfecting Solution

NCT ID: NCT01318577

Last Updated: 2020-10-08

Study Results

Results available

Outcome measurements, participant flow, baseline characteristics, and adverse events have been published for this study.

View full results

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

NA

Total Enrollment

444 participants

Study Classification

INTERVENTIONAL

Study Start Date

2010-11-30

Study Completion Date

2011-06-30

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The objective of this study is to evaluate the safety and efficacy of a new investigational cleaning and disinfecting solution (Test) compared to Clear Care cleaning and disinfecting solution (Control) when used by contact lens wearers to clean and disinfect their contact lenses for approximately three months.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Vision Disorders

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Primary Study Purpose

PREVENTION

Blinding Strategy

DOUBLE

Participants Investigators

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Investigational Solution

Hydrogen peroxide system for cleaning, protein removal, disinfecting and storing of contact lenses.

Group Type EXPERIMENTAL

Investigational Cleaning & Disinfecting Solution

Intervention Type DEVICE

Contact lenses will be cleaned and stored daily in the cleaning, disinfecting and storage solution

Clear Care Solution

Hydrogen peroxide system for cleaning, protein removal, disinfecting and storing of contact lenses

Group Type ACTIVE_COMPARATOR

Clear Care Solution

Intervention Type DEVICE

Contact lenses will be cleaned and stored daily in the cleaning, disinfecting and storage solution

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Investigational Cleaning & Disinfecting Solution

Contact lenses will be cleaned and stored daily in the cleaning, disinfecting and storage solution

Intervention Type DEVICE

Clear Care Solution

Contact lenses will be cleaned and stored daily in the cleaning, disinfecting and storage solution

Intervention Type DEVICE

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Subjects must be habitual wearers of one of the protocol specified lenses.
* Subjects must habitually use a NON-PEROXIDE lens care product for cleaning, disinfecting and storage of their lenses.
* Subjects must be adapted lens wearers and wear a lens in each eye and each lens must be of the same manufacture and brand.
* Subjects must agree to wear their lenses on a daily wear basis for approximately three months.

Exclusion Criteria

* Subjects who currently use a hydrogen peroxide cleaning and disinfecting solution.
* Subjects who currently wear Opaque Cosmetic Tint Contact Lenses.
* Subjects who have worn polymethylmethacrylate (PMMA) lenses within the last three months.
* Subjects with any systemic disease currently affecting ocular health or which in the Investigator"s opinion may have an effect on ocular health during the course of the study.
* Subjects using any systemic or topical medications that will, in the Investigator"s opinion, affect ocular physiology or lens performance.
* Subjects with any "Present" finding during the slit lamp examination that, in the Investigator"s judgment, interferes with contact lens wear.
* Subjects with any scar or neovascularization within the central 4 mm of the cornea.
* Subjects who are allergic to any component in the study care products.
Minimum Eligible Age

18 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

Yes

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Bausch & Lomb Incorporated

INDUSTRY

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Beverly Barna

Role: STUDY_DIRECTOR

Bausch & Lomb Incorporated

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Bausch & Lomb Incorporated

Rochester, New York, United States

Site Status

Countries

Review the countries where the study has at least one active or historical site.

United States

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

682

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.